Juno: Kite Pharma, Juno duke it out in court over megamillion-dollar CAR-T patent

Behind the cell and gene therapy headlines-approvals, manufacturing snafus, new data-two of the industry's biggest players have been battling over a single CAR-T patent. Kite Pharma and its cancer med Yescarta steps on a patent Juno Therapeutics licensed years ago, according to a lawsuit that went to trial this week.